Andrew P. Combs,Thomas P. Maduskuie, JR.,Nikoo Falahatpisheh
申请号：
US16658445
公开号：
US20200048251A1
申请日:
2019.10.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
